proposed that Del-AHNAK2mut increased the TMB and NAL level, activated cytotoxic T lymphocyte (CTL) effector functions and interferon-gamma (IFN)-γ signaling, and eventually initiated the therapeutic immune response of NSCLC (39). Here, NPL is linked to non-small cell lung carcinoma.